LACTO-FLAVIN
Mycobacterium Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Mycobacterium Tuberculosis cohort.
Same molecule, other indications
LACTO-FLAVIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →